loadpatents
name:-0.22780299186707
name:-0.059550046920776
name:-0.012546062469482
Braje; Wilfried Patent Filings

Braje; Wilfried

Patent Applications and Registrations

Patent applications and USPTO patent grants for Braje; Wilfried.The latest application filed is for "macrocyclic mcl-1 inhibitors and methods of use".

Company Profile
17.77.91
  • Braje; Wilfried - Wiesbaden DE
  • Braje; Wilfried - Ludwigshafen DE
  • Braje; Wilfried - Mannheim DE
  • Braje; Wilfried - Mannhaim DE
  • Braje; Wilfried - Rintein N/A DE
  • Braje; Wilfried - Rinteln DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20220259226 - Braje; Wilfried ;   et al.
2022-08-18
Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
Grant 11,312,668 - Braje , et al. April 26, 2
2022-04-26
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20210292339 - BRAJE; Wilfried ;   et al.
2021-09-23
Organic Reactions Carried Out In Aqueous Solution In The Presence Of A Hydroxyalkyl(alkyl)cellulose Or An Alkylcellulose
App 20210017100 - BRAJE; Wilfried ;   et al.
2021-01-21
Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose
Grant 10,836,688 - Braje , et al. November 17, 2
2020-11-17
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200325153 - Judd; Andrew S. ;   et al.
2020-10-15
Tricyclic Quinoline And Quinoxaline Derivatives
App 20200283439 - Koolman; Hannes ;   et al.
2020-09-10
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200255451 - Kind Code
2020-08-13
Macrocyclic Mcl-1 Inhibitors And Methods Of Use
App 20200239494 - BRAJE; Wilfried ;   et al.
2020-07-30
Organic Reactions Carried Out In Aqueous Solution In The Presence Of A Hydroxyalkyl(alkyl)cellulose Or An Alkylcellulose
App 20200148610 - BRAJE; Wilfried ;   et al.
2020-05-14
Proline Amide Compounds And Their Azetidine Analogues Carrying A Specifically Substituted Benzyl Radical
App 20200039930 - Backfisch; Gisela ;   et al.
2020-02-06
Gold-Catalyzed C-C Cross-Coupling of Boron- and Silicon-Containing Aryl Compounds and Aryldiazonium Compounds by Visible-Light
App 20200031731 - Hashmi; A. Stephen K. ;   et al.
2020-01-30
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200010480 - Brady; Patrick B. ;   et al.
2020-01-09
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2
App 20200002354 - Backfisch; Gisela ;   et al.
2020-01-02
Macrocyclic MCL-1 inhibitors and methods of use
App 20190144465 - Judd; Andrew S. ;   et al.
2019-05-16
Tricyclic Quinoline And Quinoxaline Derivatives
App 20190071443 - Koolman; Hannes ;   et al.
2019-03-07
Pyridyl Or Pyrazinyl Compounds Carrying A Methyl-bound Alpha-amino Acid Amide Group
App 20190062305 - BACKFISCH; Gisela ;   et al.
2019-02-28
Macrocyclic MCL-1 inhibitors and methods of use
App 20190055264 - Brady; Patrick B. ;   et al.
2019-02-21
Tricyclic Quinoline And Quinoxaline Derivatives
App 20190048007 - Koolman; Hannes ;   et al.
2019-02-14
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20180346484 - Akritopoulou-Zanze; Irini ;   et al.
2018-12-06
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2c-dependent Disorders
App 20180339996 - BACKFISCH; Gisela ;   et al.
2018-11-29
Tricyclic quinoline and quinoxaline derivatives
Grant 10,118,926 - Koolman , et al. November 6, 2
2018-11-06
Tricyclic quinoline and quinoxaline derivatives
Grant 9,994,568 - Koolman , et al. June 12, 2
2018-06-12
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20180127423 - Wang; Ying ;   et al.
2018-05-10
Modulators of 5-HT receptors and methods of use thereof
Grant 9,879,033 - Akritopoulou-Zanze , et al. January 30, 2
2018-01-30
Organic Reactions Carried Out In Aqueous Solution In The Presence Of A Hydroxyalkyl(alkyl)cellulose Or An Alkylcellulose
App 20170217850 - BRAJE; Wilfried ;   et al.
2017-08-03
Modulators of 5-HT receptors and methods of use thereof
Grant 9,701,679 - Wang , et al. July 11, 2
2017-07-11
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical
App 20170158693 - BACKFISCH; Gisela ;   et al.
2017-06-08
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical
App 20170112851 - BACKFISCH; Gisela ;   et al.
2017-04-27
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
Grant 9,617,226 - Braje , et al. April 11, 2
2017-04-11
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators
Grant 9,573,950 - Backfisch , et al. February 21, 2
2017-02-21
Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
Grant 9,540,376 - Backfisch , et al. January 10, 2
2017-01-10
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
Grant 9,527,856 - Braje , et al. December 27, 2
2016-12-27
Carbamate-substituted Oxindole Derivatives And Use Thereof For The Treatment Of Vasopressin-dependent Diseases
App 20160362394 - Netz; Astrid ;   et al.
2016-12-15
5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
Grant 9,434,713 - Braje , et al. September 6, 2
2016-09-06
Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
Grant 9,422,264 - Netz , et al. August 23, 2
2016-08-23
Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
Grant 9,403,796 - Oost , et al. August 2, 2
2016-08-02
Oxindole Derivatives Carrying An Oxetane Substituent Anduse Thereof For Treating Vasopressin-related Diseases
App 20160168135 - Jantos; Katja ;   et al.
2016-06-16
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20160096851 - Akritopoulou-Zanze; Irini ;   et al.
2016-04-07
Fused Heterocyclic Or Carbocyclic Compounds Carrying A Substituted Cycloaliphatic Radical And Use Thereof For Treating Vasopressin-related Diseases
App 20160068494 - Braje; Wilfried ;   et al.
2016-03-10
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)
Grant 9,242,933 - Geneste , et al. January 26, 2
2016-01-26
Tricyclic Quinoline And Quinoxaline Derivatives
App 20160016954 - Koolman; Hannes ;   et al.
2016-01-21
Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
Grant 9,238,642 - Braje , et al. January 19, 2
2016-01-19
Substituted Oxindole Derivatives And Their Use As Vasopressin Receptor Ligands
App 20150352110 - Netz; Astrid ;   et al.
2015-12-10
Oxindole Compounds Carrying A Co-bound Spiro Substituent And Use Thereof For Treating Vasopressin-related Diseases
App 20150344489 - Braje; Wilfried ;   et al.
2015-12-03
Modulators of 5-HT receptors and methods of use thereof
Grant 9,187,483 - Akritopoulou-Zanze , et al. November 17, 2
2015-11-17
Tricyclic quinoline and quinoxaline derivatives
Grant 9,169,253 - Koolman , et al. October 27, 2
2015-10-27
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical
App 20150259346 - BACKFISCH; Gisela ;   et al.
2015-09-17
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical
App 20150259343 - BACKFISCH; Gisela ;   et al.
2015-09-17
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20150175570 - Turner; Sean Colm ;   et al.
2015-06-25
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20150175611 - Wang; Ying ;   et al.
2015-06-25
5-halogen-substituted Oxindole Derivatives And Use Thereof For Treating Vasopressin-dependent Diseases
App 20150158845 - Braje; Wilfried ;   et al.
2015-06-11
5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases
Grant 9,023,854 - Braje , et al. May 5, 2
2015-05-05
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,969,552 - Drescher , et al. March 3, 2
2015-03-03
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
Grant 8,957,089 - Amberg , et al. February 17, 2
2015-02-17
Substituted Oxindole Derivatives And Their Use As Vasopressin Receptor Ligands
App 20140378471 - Netz; Astrid ;   et al.
2014-12-25
Carbamate-substituted Oxindole Derivatives And Use Thereof For The Treatment Of Vasopressin-dependent Diseases
App 20140315914 - Netz; Astrid ;   et al.
2014-10-23
Substituted Oxindole-derivatives And The Use Thereof For The Treatment Of Vasopressin-dependent Illnesses
App 20140303138 - Braje; Wilfried ;   et al.
2014-10-09
Modulators of 5-HT receptors and methods of use thereof
Grant 8,846,663 - Wang , et al. September 30, 2
2014-09-30
Modulators of 5-HT receptors and methods of use thereof
Grant 8,846,951 - Akritopoulou-Zanze , et al. September 30, 2
2014-09-30
Amidomethyl-substituted Oxindole Derivatives And The Use Thereof For The Treatment Of Vasopressin-dependent Illnesses
App 20140275110 - Oost; Thorsten ;   et al.
2014-09-18
Substituted oxindole derivatives and their use as vasopressin receptor ligands
Grant 8,815,868 - Netz , et al. August 26, 2
2014-08-26
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20140200224 - Turner; Sean Colm ;   et al.
2014-07-17
5,6-disubstituted Oxindole-derivatives And Use Thereof For Treating Vasopressin-dependent Diseases
App 20140194440 - Braje; Wilfried ;   et al.
2014-07-10
Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
Grant 8,703,775 - Oost , et al. April 22, 2
2014-04-22
Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
Grant 8,703,774 - Netz , et al. April 22, 2
2014-04-22
Tricyclic Quinoline And Quinoxaline Derivatives
App 20140080813 - Braje; Wilfried
2014-03-20
Tricyclic Quinoline And Quinoxaline Derivatives
App 20140080814 - Braje; Wilfried
2014-03-20
Tricyclic Quinoline And Quinoxaline Derivatives
App 20140080816 - Koolman; Hannes ;   et al.
2014-03-20
Small molecule potentiators of metabotropic glutamate receptors I
Grant 8,664,214 - Braje , et al. March 4, 2
2014-03-04
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
Grant 8,653,100 - Ochse , et al. February 18, 2
2014-02-18
Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
Grant 8,629,148 - Braje , et al. January 14, 2
2014-01-14
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20130310368 - Wang; Ying ;   et al.
2013-11-21
Modulators of 5-HT receptors and methods of use thereof
Grant 8,546,377 - Wang , et al. October 1, 2
2013-10-01
5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
Grant 8,546,401 - Braje , et al. October 1, 2
2013-10-01
Modulators of 5-HT receptors and methods of use thereof
Grant 8,518,933 - Wang , et al. August 27, 2
2013-08-27
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,507,469 - Schultz , et al. August 13, 2
2013-08-13
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
App 20130203749 - Amberg; Wilhelm ;   et al.
2013-08-08
1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,492,540 - Braje , et al. July 23, 2
2013-07-23
Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,486,984 - Drescher , et al. July 16, 2
2013-07-16
N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor
Grant 8,476,275 - Braje , et al. July 2, 2
2013-07-02
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,470,810 - Drescher , et al. June 25, 2
2013-06-25
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT.sub.6 receptor
Grant 8,440,694 - Turner , et al. May 14, 2
2013-05-14
4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
Grant 8,420,670 - Amberg , et al. April 16, 2
2013-04-16
Quinoline Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin-5-ht6 Receptor
App 20130005703 - Turner; Sean Colm ;   et al.
2013-01-03
Substituted Oxindole Derivatives And Their Use As Vasopressin Receptor Ligands
App 20120322809 - Netz; Astrid ;   et al.
2012-12-20
Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
Grant 8,334,289 - Geneste , et al. December 18, 2
2012-12-18
Small molecule potentiators of metabotropic glutamate receptors
Grant 8,314,120 - Braje , et al. November 20, 2
2012-11-20
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT.sub.6 receptor
Grant 8,293,913 - Turner , et al. October 23, 2
2012-10-23
Pyrimidine compounds and use thereof
Grant 8,268,815 - Geneste , et al. September 18, 2
2012-09-18
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20120220635 - Drescher; Karla ;   et al.
2012-08-30
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
Grant 8,242,102 - Turner , et al. August 14, 2
2012-08-14
Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,232,426 - Drescher , et al. July 31, 2
2012-07-31
Tetrahydrobenzazepines and their use in he modulation of the dopamine D.sub.3 receptor
Grant 8,207,160 - Braje , et al. June 26, 2
2012-06-26
4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,202,868 - Haupt , et al. June 19, 2
2012-06-19
Triazole Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20120095015 - Unger; Liliane ;   et al.
2012-04-19
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,101,754 - Unger , et al. January 24, 2
2012-01-24
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20110319421 - Turner; Sean Colm ;   et al.
2011-12-29
N-[piperazinyl Hetaryl]arylsufonamide Compounds With Affinity For The Dopamine D3 Receptor
App 20110294817 - Braje; Wilfried ;   et al.
2011-12-01
Isoindolinone Kinase Inhibitors
App 20110275630 - Matulenko; Mark ;   et al.
2011-11-10
Novel Small Molecule Potentiators Of Metabotropic Glutamate Receptors
App 20110245247 - Braje; Wilfried ;   et al.
2011-10-06
Pyridin-2-one Compounds And Their Use As Modulators Of The Dopamine D3 Receptor
App 20110245266 - Geneste; Herve ;   et al.
2011-10-06
Novel Small Molecule Potentiators Of Metabotropic Glutamate Receptors I
App 20110245232 - Braje; Wilfried ;   et al.
2011-10-06
Pyrimidin-2-one compounds and their use as dopamine D.sub.3 receptor ligands
Grant 8,008,488 - Geneste , et al. August 30, 2
2011-08-30
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20110160176 - Drescher; Karla ;   et al.
2011-06-30
Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
App 20110144146 - Drescher; Karla ;   et al.
2011-06-16
Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
Grant 7,960,386 - Geneste , et al. June 14, 2
2011-06-14
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20110130382 - Wang; Ying ;   et al.
2011-06-02
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20110118231 - Akritopoulou-Zanze; Irini ;   et al.
2011-05-19
Pyrimidine Compounds And Use Thereof
App 20110118232 - Geneste; Herve ;   et al.
2011-05-19
Tetrahydroisoquinolines, Pharmaceutical Compositions Containing Them, And Their Use In Therapy
App 20110105502 - Amberg; Wilhelm ;   et al.
2011-05-05
Substituted Oxindole-derivatives And The Use Thereof For The Treatment Of Vasopressin-dependent Illnesses
App 20110105454 - Braje; Wilfried ;   et al.
2011-05-05
5,6-disubstituted Oxindole-derivatives And Use Thereof For Treating Vasopressin-dependent Diseases
App 20110092513 - Braje; Wilfried ;   et al.
2011-04-21
5-halogen-substituted Oxindole Derivatives And Use Thereof For Treating Vasopressin-dependent Diseases
App 20110092516 - Braje; Wilfried ;   et al.
2011-04-21
Amidomethyl-substituted Oxindole Derivatives And The Use Thereof For The Treatment Of Vasopressin-dependent Illnesses
App 20110077253 - Oost; Thorsten ;   et al.
2011-03-31
Carbamate-substituted Oxindole Derivatives And Use Thereof For The Treatment Of Vasopressin-dependent Diseases
App 20110065720 - Netz; Astrid ;   et al.
2011-03-17
Use Of Substituted Oxindole Derivatives For The Treatment And Prophylaxis Of Pain
App 20110059983 - Braje; Wilfried ;   et al.
2011-03-10
Quinoline Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20110009380 - Turner; Sean Colm ;   et al.
2011-01-13
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 7,851,463 - Drescher , et al. December 14, 2
2010-12-14
1,2,4,-triazin-3,5-dione Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20100311755 - Braje; Wilfried ;   et al.
2010-12-09
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20100298292 - Akritopoulou-Zanze; Irini ;   et al.
2010-11-25
Quinoline Compounds Suitable for Treating Disorders that Respond to Modulation of the Serotonin-5-HT6 Receptor
App 20100292271 - Turner; Sean Colm ;   et al.
2010-11-18
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 7,834,048 - Drescher , et al. November 16, 2
2010-11-16
Modulators Of 5-ht Receptors And Methods Of Use Thereof
App 20100273767 - Wang; Ying ;   et al.
2010-10-28
4-benzylaminoquinolines, Pharmaceutical Compositions Containing Them, And Their Use In Therapy
App 20100222346 - Amberg; Wilhelm ;   et al.
2010-09-02
Pyrimidine compounds and use thereof
Grant 7,786,105 - Geneste , et al. August 31, 2
2010-08-31
6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 7,759,397 - Drescher , et al. July 20, 2
2010-07-20
Azetidin Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20100137280 - Schultz, SR.; Thomas ;   et al.
2010-06-03
Keto lactam compounds and use thereof
Grant 7,723,384 - Lubisch , et al. May 25, 2
2010-05-25
4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20090264437 - Haupt; Andreas ;   et al.
2009-10-22
Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
App 20090105224 - Braje; Wilfried ;   et al.
2009-04-23
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
App 20090048326 - Drescher; Karla ;   et al.
2009-02-19
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
App 20090012074 - Drescher; Karla ;   et al.
2009-01-08
6-Amino(Aza)Indane Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20080318996 - Drescher; Karla ;   et al.
2008-12-25
HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor)
App 20080300260 - GENESTE; Herve ;   et al.
2008-12-04
Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
App 20080261992 - Geneste; Herve ;   et al.
2008-10-23
Triazole Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20080171751 - Unger; Liliane ;   et al.
2008-07-17
Pyrimidine Compounds and Use Thereof
App 20080161322 - Geneste; Herve ;   et al.
2008-07-03
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20080096934 - Drescher; Karla ;   et al.
2008-04-24
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20080045493 - Drescher; Karla ;   et al.
2008-02-21
N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor
App 20070054918 - Braje; Wilfried ;   et al.
2007-03-08
Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
App 20060235004 - Geneste; Herve ;   et al.
2006-10-19
Dibenzodiazepine derivatives, their preparation and use
Grant 7,026,311 - Lubisch , et al. April 11, 2
2006-04-11
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 6,919,342 - Haupt , et al. July 19, 2
2005-07-19
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
App 20040259882 - Haupt, Andreas ;   et al.
2004-12-23
Dibenzodiazepine derivatives, their preparation and use
App 20030139394 - Lubisch, Wilfried ;   et al.
2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed